Abdominal Aortic Diameter and the Risk for Asymptomatic Peripheral Arterial Disease in Patients with Type 2 Diabetes

Abstract

Peripheral arterial disease (PAD) is common among older people because it often results from atherosclerosis, which becomes more common with age. The disease is particularly common among people who have diabetes. Little information is available on the relation between abdominal aortic diameter and PAD in elderly patients with diabetes. This article studies the relationships between abdominal aortic diameter, PAD, and the cardiovascular risk factors in asymptomatic elderly patients suffering from type 2 diabetes mellitus. A case–control study was conducted on 90 participants aged 60 years and older divided into 60 cases (30 males and 30 females) and 30 age-matched healthy controls (15 males and 15 females). The relationships between the size of the abdominal aorta and ankle–brachial index (ABI), plasma cholesterol, triglycerides (TG), and high-sensitivity C-reactive protein were examined. Approximately, 15% of patients with diabetes had asymptomatic PAD. The patients with diabetes with PAD were of older age (70.4 ± 3.6 vs. 63.4 ± 3.9 years; p = 0.000), had larger abdominal aortic diameter (22.4 ± 3.08 vs. 18.7 ± 2 mm; p = 0.000), and higher CRP levels (8.3 ± 1.1 vs. 5.8 ± 2.2 mg/L; p = 0.002), while other variables revealed no significant difference. Abdominal aortic diameter correlated well with ABI measured by Doppler method in diabetic patients (r =  − 0.471, p = 0.000). Older age and larger abdominal aorta are independent risk factors for asymptomatic PAD in the elderly with type 2 diabetes mellitus.

Keywords

peripheral arterial disease - abdominal aortic diameter - diabetes mellitus - ankle–brachial index - C-reactive protein

Note

All authors have read and approved the submission of the manuscript. The manuscript has not been published and is not under consideration of publication in whole or part except as an abstract.

• References

• 1 Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol 2006; 47 (5) 921-929
• 2 Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287 (19) 2570-2581
• 3 Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110 (6) 738-743
• 4 Gregg EW, Sorlie P, Paulose-Ram R , et al; 1999-2000 national health and nutrition examination survey. Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care 2004; 27 (7) 1591-1597
• 5 Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 2001; 24 (8) 1433-1437
• 6 American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003; 26 (12) 3333-3341
• 7 Palazzuoli A, Gallotta M, Guerrieri G , et al. Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: comparison with high cardiovascular risk population. Vasc Health Risk Manag 2008; 4 (4) 877-883
• 8 Ahlgren AR, Hansen F, Sonesson B, Länne T. Stiffness and diameter of the common carotid artery and abdominal aorta in women. Ultrasound Med Biol 1997; 23 (7) 983-988
• 9 Meijer WT, Grobbee DE, Hunink MG, Hofman A, Hoes AW. Determinants of peripheral arterial disease in the elderly: the Rotterdam study. Arch Intern Med 2000; 160 (19) 2934-2938
• 10 Allardice JT, Allwright GJ, Wafula JMC, Wyatt AP. High prevalence of abdominal aortic aneurysm in men with peripheral vascular disease: screening by ultrasonography. Br J Surg 1988; 75 (3) 240-242
• 11 Galland RB, Simmons MJ, Torrie EP. Prevalence of abdominal aortic aneurysm in patients with occlusive peripheral vascular disease. Br J Surg 1991; 78 (10) 1259-1260
• 12 Pedersen OM, Aslaksen A, Vik-Mo H. Ultrasound measurement of the luminal diameter of the abdominal aorta and iliac arteries in patients without vascular disease. J Vasc Surg 1993; 17 (3) 596-601
• 13 Mohler III ER. Peripheral arterial disease: identification and implications. Arch Intern Med 2003; 163 (19) 2306-2314
• 14 Weiss JS, Sumpio BE. Review of prevalence and outcome of vascular disease in patients with diabetes mellitus. Eur J Vasc Endovasc Surg 2006; 31 (2) 143-150
• 15 Elhadd T, Robb R, Jung R, Stonebridge P, Belch J. Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. Pract Diabetes Int 1999; 16: 163-166
• 16 Hirsch AT, Criqui MH, Treat-Jacobson D , et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286 (11) 1317-1324
• 17 Golledge J, Karan M, Moran CS , et al. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. Eur Heart J 2008; 29 (5) 665-672
• 18 Shantikumar S, Ajjan R, Porter KE, Scott DJ. Diabetes and the abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2010; 39 (2) 200-207
• 19 Le MT, Jamrozik K, Davis TM, Norman PE. Negative association between infra-renal aortic diameter and glycaemia: the Health in Men Study. Eur J Vasc Endovasc Surg 2007; 33 (5) 599-604
• 20 Allison MA, Kwan K, DiTomasso D, Wright CM, Criqui MH. The epidemiology of abdominal aortic diameter. J Vasc Surg 2008; 48 (1) 121-127
• 21 Tavintharan S, Ning Cheung, Tay W, Shankar A, Shyong Tai E, Wong TY ; Su Chi Lim. Prevalence and risk factors for peripheral artery disease in an Asian population with diabetes mellitus. Diab Vasc Dis Res 2009; 6 (2) 80-86
• 22 Allison MA, Criqui MH, McClelland RL , et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2006; 48 (6) 1190-1197
• 23 Al-Delaimy WK, Merchant AT, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men. Am J Med 2004; 116 (4) 236-240
• 24 Rajkumar C, Bonapace S, Starr J, Radia M, Bulpitt CJ. Association between abdominal aortic diameter and peripheral vascular disease. J Hum Hypertens 1997; 11 (9) 589-591
• 25 Shankar A, Li J, Nieto FJ, Klein BE, Klein R. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension. Am Heart J 2007; 154 (3) 495-501
• 26 Doi Y, Kiyohara Y, Kubo M , et al. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study. Diabetes Care 2005; 28 (10) 2497-2500
• 27 Mugabo Y, Li L, Renier G. The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings. Curr Diabetes Rev 2010; 6 (1) 27-34
• 28 Vu JD, Vu JB, Pio JR , et al. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease. Am J Cardiol 2005; 96 (5) 655-658